Organization: Canopy Growth Corporation

The Short Report, June 26, 2019: Dementia, Ontario chief scientist, AI for travel

The Canadian Consortium on Neurodegeneration in Aging is receiving $46 million over five years: $31.6 million from the Canadian Institutes of Health Research and $14.4 million from partners, including the Alzheimer Society. Headquartered at Baycrest in Toronto, the second phase of CCNA’s research program will include a large-scale study to evaluate the effectiveness of new…

M-J Milloy

Univ of British Columbia hired epidemiologist Dr. M-J Milloy as its first Canopy Growth Professor of Cannabis Science. The initial aim of this professorship is to lead clinical trials that will explore ways that cannabis-based therapy can help people with opioid abuse disorder stay on their treatment plan. Opioid overdoses killed an estimated 1,143 people…

Canada’s Canopy Growth Corporation acquires Colorado-based hemp research company

The Canadian cannabis and hemp company Canopy Growth Corporation, which operates a field-scale hemp operation in Saskatchewan, will pay CAD$25 million and issue 6,221,210 shares to acquire the assets of ebbu, Inc., a Colorado-based hemp research leader. Canopy Growth will apply ebbu’s IP and R&D advancements directly to its hemp and THC-rich cannabis genetic breeding…